First U.S. trial uses non-viral CRISPR to correct sickle cell mutation

This post was originally published on News-medical.net

You will shortly be re-directed to the publisher's website

UCSF Benioff Children’s Hospital Oakland is enrolling patients in an innovative clinical trial that seeks to cure sickle cell disease.